SUBSCRIBE
SUBSCRIBE
News   Deals

Pantarhei to Bid for Merck & Co., Inc.'s Organon Unit

February 14, 2011 | 
1 min read
Reuters) - Dutch bioscience company Pantarhei intends to bid for the bulk of U.S. company Merck's (MRK.N) Netherlands-based bioscience research unit Organan, the Dutch Financieele Dagblad reported on Monday.
Mergers & acquisitions Europe
Merck & Co. Organon
MORE ON THIS TOPIC
People balance on tightly stretched ropes. Art collage.
Deals
M&A, IPOs Snarled by Policy Reality in Q1 as Pharmas Opt for Licensing Deals
May 7, 2025
 · 
3 min read
 · 
Annalee Armstrong
Brain shaped maze. Conceptual image of science and medicine. 3D illustration.
ALS
Lilly Deepens ALS Pipeline With $415M Alchemab Licensing Deal
May 6, 2025
 · 
2 min read
 · 
Tristan Manalac
Business and financial crisis vector concept with businessman falling down the hole. Symbol of market crash, recession, risk, bankruptcy and loss. Eps10 illustration.
Mergers & acquisitions
Kronos Accepts $35M Concentra Buyout as Walls Close In
May 2, 2025
 · 
2 min read
 · 
Annalee Armstrong
Creative design. Desperate employee, office worker standing near question mark symbolizing business struggles, options. Choosing strategy for achieving goal. Concept of business, career development
Earnings
Tariffs Keep Biogen Execs Busy in Q1 but Impacts Expected To Be Minimal
May 1, 2025
 · 
3 min read
 · 
Annalee Armstrong